SCHEMBL25723809

SCHEMBL25723809

CC(C)c1[nH]c2ccccc2c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 4/20 0.46
▸ ALDH1A1 P00352 7/20 0.44
▸ HSD17B10 Q99714 4/20 0.44
▸ GPR3 P46089 2/20 0.44
▸ TBXAS1 P24557 1/20 0.44
▸ HPGD P15428 3/20 0.43
▸ CCNB2 O95067 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ CCNB3 Q8WWL7 1/20 0.41
▸ AHR P35869 2/20 0.41
▸ ALOX15 P16050 1/20 0.40
▸ VDR P11473 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNA7 P36544 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ GLA P06280 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ HTT P42858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10280325 0.79 CCNB2 (0.56) KIF11ALDH1A1HSD17B10GPR3TBXAS1
SCHEMBL30234429 0.79 CCNB2 (0.56) KIF11ALDH1A1HSD17B10GPR3TBXAS1
SCHEMBL10067381 0.78 AHR (0.57) KIF11ALDH1A1HSD17B10GPR3TBXAS1
SCHEMBL13104334 0.76 CCNB2 (0.49) KIF11ALDH1A1HSD17B10GPR3TBXAS1
SCHEMBL23890566 0.76 ALDH1A1 (0.46) KIF11ALDH1A1HSD17B10GPR3TBXAS1
SCHEMBL22479060 0.76 KIF11 (0.46) KIF11ALDH1A1KDM4EGAAHTT
SCHEMBL23511225 0.74 ACHE (0.47) KIF11ALDH1A1TBXAS1HPGDKDM4E
SCHEMBL14597253 0.73 ALDH1A1 (0.61) KIF11ALDH1A1HSD17B10GPR3TBXAS1
SCHEMBL13408067 0.73 TBXAS1 (0.56) KIF11ALDH1A1HSD17B10GPR3TBXAS1
SCHEMBL19126160 0.73 ESR1 (0.58) KIF11ALDH1A1HSD17B10TBXAS1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114428-A1 HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF DISEASE Vir Biotechnology, Inc. (US) 2023-06-22 — — WO disclosed
Send feedback